๐‚๐š๐ญ๐ก๐ž๐ญ๐ž๐ซ-๐‘๐ž๐ฅ๐š๐ญ๐ž๐ ๐๐ฅ๐จ๐จ๐๐ฌ๐ญ๐ซ๐ž๐š๐ฆ ๐ˆ๐ง๐Ÿ๐ž๐œ๐ญ๐ข๐จ๐ง ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐š๐ง๐ ๐†๐ซ๐จ๐ฐ๐ญ๐ก 2032

๐‘๐ž๐š๐ ๐ฆ๐จ๐ซ๐ž: https://www.reportsandinsights.....com/report/catheter

Business

The global catheter-related bloodstream infection drugs market was valued at US$ 1.6 Billion in 2023 and is expected to register a CAGR of 5.7% over the forecast period and reach US$ 2.6 Billion in 2032.